EPO and chronic hepatitis C virus infection: In patients with chronic hepatitis C receiving antiviral treatment, homozygosity for the EPO rs1617640 CC genotype was associated with a weaker rise in erythropoietin levels and a more frequent need for blood transfusion [15].